Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Corey

Showing results (491-500 of 511) with videos related to

Pageof 52
Sort By:
The American Journal of Gastroenterology|February 8, 2022
Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular CarcinomaBlanca C Lizaola-Mayo, Amit K Mathur, Mitesh-J Borad, et al.
The American Journal of Medicine|July 20, 1982
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infectionsL Corey, J K Benedetti, C W Critchlow, et al.
American Journal of Epidemiology|September 18, 1999
Risk factors for HIV-1 shedding in semenC E Speck, R W Coombs, L A Koutsky, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2012
Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ringM J Keller, A M Malone, C A Carpenter, et al.
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
The Journal of Infectious Diseases|August 11, 1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient dataJ P Ioannidis, A C Collier, D A Cooper, et al.
AIDS Research and Human Retroviruses|January 12, 2001
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1R Bures, A Gaitan, T Zhu, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|June 18, 2021
Feasibility of a Web-Accessible Game-Based Intervention Aimed at Improving Help Seeking and Coping Among Sexual and Gender Minority Youth: Results From a Randomized Controlled TrialJames E Egan, Stephanie L Corey, Emmett R Henderson, et al.
AIDS Research and Human Retroviruses|October 6, 1997
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation GroupM C Keefer, M Wolff, G J Gorse, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.
Pageof 52

Showing results (491-500 of 511) with videos related to

Sort By:
Pageof 52
The American Journal of Gastroenterology|February 8, 2022
Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular CarcinomaBlanca C Lizaola-Mayo, Amit K Mathur, Mitesh-J Borad, et al.
The American Journal of Medicine|July 20, 1982
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infectionsL Corey, J K Benedetti, C W Critchlow, et al.
American Journal of Epidemiology|September 18, 1999
Risk factors for HIV-1 shedding in semenC E Speck, R W Coombs, L A Koutsky, et al.
The Journal of Antimicrobial Chemotherapy|May 5, 2012
Safety and pharmacokinetics of aciclovir in women following release from a silicone elastomer vaginal ringM J Keller, A M Malone, C A Carpenter, et al.
The New England Journal of Medicine|April 18, 1996
Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials GroupA C Collier, R W Coombs, D A Schoenfeld, et al.
The Journal of Infectious Diseases|August 11, 1998
Clinical efficacy of high-dose acyclovir in patients with human immunodeficiency virus infection: a meta-analysis of randomized individual patient dataJ P Ioannidis, A C Collier, D A Cooper, et al.
AIDS Research and Human Retroviruses|January 12, 2001
Immunization with recombinant canarypox vectors expressing membrane-anchored glycoprotein 120 followed by glycoprotein 160 boosting fails to generate antibodies that neutralize R5 primary isolates of human immunodeficiency virus type 1R Bures, A Gaitan, T Zhu, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|June 18, 2021
Feasibility of a Web-Accessible Game-Based Intervention Aimed at Improving Help Seeking and Coping Among Sexual and Gender Minority Youth: Results From a Randomized Controlled TrialJames E Egan, Stephanie L Corey, Emmett R Henderson, et al.
AIDS Research and Human Retroviruses|October 6, 1997
Safety profile of phase I and II preventive HIV type 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation GroupM C Keefer, M Wolff, G J Gorse, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 7, 1997
The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremiaG Pantaleo, J F Demarest, T Schacker, et al.
Pageof 52